To investigate the association between breast cancer development and the IL-22 receptor, IL-22R1 and S1PR1 expression signatures, we compared the mRNA expression of IL-22R1 and S1PR1 in luminal and basal/triple-negative subtypes of breast cancer cell lines and breast tumors. Here, IL22RA1 is linked to breast cancer.